封面
市場調查報告書
商品編碼
1629902

全球過濾針市場 - 2025-2033

Global Filter Needles Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年,全球過濾針市場規模達18億美元,預計2033年將達到36億美元,2025-2033年預測期間複合年成長率為7.7%。

過濾針是醫療保健環境中使用的醫療設備,可將藥物從小瓶或安瓿安全地註入注射器而不會受到污染。這些設備通常由帶有整合過濾器的空心針組成,該過濾器允許流體通過,同時阻擋玻璃碎片、橡膠顆粒和其他污染物等顆粒物。針頭設計有疏水過濾器,可以捕獲任何顆粒,確保給藥的藥物不受污染物的影響。當處理對污染敏感的注射藥物或從玻璃安瓿中抽取藥物時,這一點尤其重要。

由於各種因素,包括慢性病盛行率的增加以及醫療機構中對感染控制的日益重視,過濾針市場的需求量很大。例如,根據美國疾病管制與預防中心 (CDC) 的數據,估計有 1.29 億美國人患有至少一種美國定義的主要慢性病(例如心臟病、癌症、糖尿病、肥胖、高血壓)衛生與公眾服務部。針設計的技術進步也透過提高安全性和效率來推動需求。由於這些因素在醫療程序中仍然至關重要,預計該市場將繼續成長,特別是在醫療基礎設施不斷擴大和可支配收入增加的地區。

市場動態:

驅動程式和限制

不斷增加的外科和醫療程序

不斷成長的外科和醫療程序極大地推動了過濾針市場的成長,預計將在預測期內推動市場的成長。全球手術數量不斷增加,特別是在新興市場,導致對過濾針等無菌設備的需求增加,以防止污染並確保給藥期間的藥物安全。例如,根據胸腔外科年鑑簡短報告,估計每年進行 100 至 150 萬例心臟外科手術。

此外,根據美國國立衛生研究院 (NIH) 進行的研究,每年為 88,273 名人口進行 4,642 例手術。白內障(22.8%)、剖腹產(3.8%)、骨折手術(3.27%)和疝氣(2.86%)是最常見的手術。 44.2%的手術屬於必要手術。 NIH 估計,每 10 萬印度人每年需要進行 3,646 次手術。此外,根據胸腔外科年鑑簡短報告,估計每年進行 100 至 150 萬例心臟外科手術。

過濾針設計的技術改進,例如整合安全功能和增強材料,可實現更好的過濾能力並降低污染風險。這些進步滿足了執行複雜手術的醫療保健提供者日益成長的需求。

針相關傷害的風險

由於對安全性的擔憂以及對醫護人員福祉的影響,與針頭相關的傷害風險極大地阻礙了過濾針頭市場的成長。儘管過濾針技術的進步旨在最大限度地減少污染並提高安全性,但意外針刺傷的風險仍然是一個關鍵問題,特別是在醫院、診所和家庭醫療保健機構等控制較少的環境中。

與針有關的傷害仍然很普遍,影響著醫護人員和病人。這些傷害可能會導致嚴重後果,包括受污染的針頭引起的感染。這種風險阻礙了過濾針的採用,特別是在擔心遵守安全協議的機構和醫療保健提供者中。例如,美國疾病管制與預防中心 (CDC) 報告稱,每年發生超過 100 萬起針刺傷和銳器傷 (NSSI) 事件,佔院內傷害的 8%。

治療傷害和實施安全措施的經濟負擔相當大。當傳統針頭仍然廣泛使用時,許多醫院和診所對於投資更昂貴的過濾針頭猶豫不決,因為人們認為受傷的風險較低。在醫療保健專業人員培訓和意識不足的地區,過濾針的誤用或誤用可能會導致受傷。這導致這些安全設備的採用率緩慢,阻礙了市場成長。

目錄

第1章:市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章:高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的片段
  • 按材料分類
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章:動力學

  • 影響因素
    • 促進要素
      • 不斷增加的外科和醫療程序
      • 整合過濾針系統的開發
    • 限制
      • 針相關傷害的風險
    • 機會
    • 影響分析

第 4 章:策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析:最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章:過濾針市場,依產品類型

  • 鈍過濾針
  • 通風過濾針
  • 客製化過濾針

第 6 章:過濾針市場(按材料)

  • 塑膠
  • 不銹鋼
  • 玻璃

第 7 章:過濾針市場,依應用

  • 藥物準備
  • 藥物輸送
  • 血液採集和處理
  • 其他

第 8 章:過濾針市場(依最終用戶)

  • 醫院
  • 專科診所
  • 門診手術中心
  • 診斷實驗室
  • 學術研究機構
  • 其他

第 9 章:過濾針市場,按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 11 章:公司簡介

  • Becton, Dickinson, and Company
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • B. Braun Medical Inc.
  • Cardinal Health
  • MYCO Medical Supplies, Inc.
  • Terumo Corporation
  • ICU Medical, Inc.
  • GBUK Group Ltd.
  • Changzhou SUNTON Medical Technology Co., Ltd
  • Medline Industries, LP

第 12 章:假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章:附錄

簡介目錄
Product Code: MD8936

The global filter needles market reached US$ 1.8 billion in 2024 and is expected to reach US$ 3.6 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.

Filter needles are medical devices used in healthcare settings to safely administer medications from vials or ampoules into syringes without contamination. These devices typically consist of a hollow needle with an integrated filter that allows fluids to pass through while blocking particulates such as glass shards, rubber particles, and other contaminants. The needle is designed with a hydrophobic filter to trap any particles, ensuring that the drugs administered are free from contaminants. This is particularly important when dealing with injectable drugs that are sensitive to contamination or when drawing drugs from glass ampoules.

The filter needles market is experiencing significant demand due to various factors, including the increasing prevalence of chronic diseases and the growing emphasis on infection control in healthcare settings. For instance, according to the Centers for Disease Control and Prevention (CDC), an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Technological advancements in needle design are also driving demand by improving safety and efficiency. The market is expected to continue growing as these factors remain critical in medical procedures, particularly in regions with expanding healthcare infrastructure and increasing disposable incomes.

Market Dynamics: Drivers & Restraints

Rising surgical and medical procedures

The rising surgical and medical procedures are significantly driving the growth of the filter needles market and are expected to drive the market over the forecast period. The rising number of surgeries worldwide, particularly in emerging markets, has led to higher demand for sterile equipment like filter needles to prevent contamination and ensure drug safety during administration. For instance, according to the Annals of Thoracic Surgery Short Reports, estimated that 1 to 1.5 million cardiac surgical procedures take place each year.

Additionally, according to the study conducted by the National Institute of Health(NIH), a total of 4,642 surgeries were performed per year for a population of 88,273. Cataracts (22.8%), Caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the commonest surgeries. 44.2% of surgeries belonged to the essential surgeries. NIH estimated that 3,646 surgeries would be required per 100,000 Indian population per year. Additionally, according to the Annals of Thoracic Surgery Short Reports, estimated that 1 to 1.5 million cardiac surgical procedures take place each year.

Technological improvements in filter needle design, such as integrated safety features and enhanced materials, allow better filtering capabilities and reduce contamination risks. These advancements cater to the increased demand from healthcare providers performing complex procedures.

Risk of needle-related injuries

The risk of needle-related injuries significantly hampers the growth of the filter needles market due to concerns over safety and the impact on healthcare workers' well-being. Despite advancements in filter needle technology designed to minimize contamination and improve safety, the risk of accidental needlestick injuries remains a critical issue, particularly in less controlled environments such as hospitals, clinics, and in-home healthcare settings.

Needle-related injuries are still prevalent, affecting healthcare workers and patients. These injuries can lead to serious consequences, including infections from contaminated needles. This risk discourages the adoption of filter needles, especially among institutions and healthcare providers who are concerned about compliance with safety protocols. For instance, the Centre for Disease Control and Prevention (CDC) reported that more than 1 million events of needle sticks and sharp injuries (NSSIs) have happened annually and represent 8% of in-hospital injuries.

The economic burden of treating injuries and implementing safety measures is considerable. Many hospitals and clinics are hesitant to invest in more expensive filter needles when traditional needles are still widely used, given the perceived lower risk of injury. In regions with inadequate training and awareness among healthcare professionals, the misuse or misapplication of filter needles can lead to injuries. This has resulted in a slow adoption rate of these safety devices, thereby hampering market growth.

Segment Analysis

The global filter needles market is segmented based on product type, material, application, end-user and region.

Product Type:

The blunt filter needles segment is expected to dominate the filter needles market share

Blunt filter needles are designed to prevent needlestick injuries and glove perforations risks by using a blunt, non-piercing tip. This makes them ideal for accessing medication vials and ampules without the risk of piercing through the vial's rubber stopper. This design reduces the risk of glass particles from ampules entering the medication during preparation, which is crucial for patient safety, especially when handling high-risk drugs and biologics. The use of blunt filter needles prevents injuries that could lead to serious health risks such as infections from accidental needle sticks.

For instance, according to the National Institute of Health (NIH), the use of blunt needles reduced the risk of glove perforations with a relative risk (RR) of 0.46 (95% confidence interval (CI) 0.38 to 0.54) compared to sharp needles. The use of blunt needles will thus prevent one glove perforation in every six operations.

Hospitals and clinics frequently use blunt filter needles for drug administration and sample collection due to their ability to handle medications without contamination risks. This widespread use has established the segment as a standard in medical procedures where sterility and safety are paramount. Home healthcare adoption of blunt filter needles also boosting as patients and caregivers prefer safer, user-friendly options for self-administration of medications.

Geographical Analysis

North America is expected to hold a significant position in the filter needles market share

North America boasts a well-established healthcare infrastructure with widespread adoption of advanced medical technologies. The presence of a high number of hospitals, clinics, and outpatient settings that require sterile drug administration has increased the demand for filter needles.

For instance, according to the American Hospital Association, there are 6,120 hospitals in the United States, in that Community Hospitals are 5,129, Federal Government Hospitals are 207 and Nonfederal Psychiatric Hospitals are 659. The U.S., in particular, leads the market due to its high healthcare expenditure and the prevalence of chronic diseases that necessitate frequent medication administration.

In North America, there is a strong preference for safety-engineered needles, including blunt filter needles, due to the heightened awareness of healthcare-associated infections. These devices are widely used to minimize the risk of needlestick injuries, which are prevalent in healthcare settings. The use of blunt filter needles is particularly emphasized for drug administration, especially when dealing with biologics and high-risk medications.

The higher economic capabilities in North America enable healthcare facilities to invest in advanced and sometimes more expensive medical devices, including filter needles. This economic advantage, coupled with reimbursement policies that support the use of safer devices, has further propelled the dominance of the filter needles market in this region.

Asia-Pacific is growing at the fastest pace in the filter needles market

The APAC region is experiencing rapid economic growth, which is leading to increased investments in healthcare infrastructure. This economic growth enables governments and private entities to improve medical facilities and access to healthcare services, thereby driving demand for advanced medical devices like filter needles.

For instance, countries like China and India are investing heavily in healthcare infrastructure, which is crucial for the adoption of safety-engineered needles. These investments include upgrading hospitals, clinics, and other medical facilities, making it easier to implement devices like filter needles.

There is a growing awareness among healthcare providers and the general population in the APAC region about the importance of infection control and patient safety. This has led to an increased demand for safety-engineered needles, such as blunt filter needles, which are effective in reducing the risk of contamination and needlestick injuries. For instance, the adoption of filter needles in countries like India and Indonesia is accelerating due to improved healthcare policies and rising awareness about safe drug administration practices.

Competitive Landscape

The major global players in the filter needles market include Becton, Dickinson, and Company, B. Braun Medical Inc., Cardinal Health, MYCO Medical Supplies, Inc., Terumo Corporation, ICU Medical, Inc., GBUK Group Ltd., Changzhou SUNTON Medical Technology Co., Ltd, Medline Industries, LP and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global filter needles market report delivers a detailed analysis with 67 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Surgical and Medical Procedures
      • 3.1.1.2. Development of Integrated Filter Needle Systems
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Needle-Related Injuries
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Filter Needles Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Blunt Filter Needles*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Vented Filter Needles
  • 5.4. Custom Filter Needles

6. Filter Needles Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Plastic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Stainless Steel
  • 6.4. Glass

7. Filter Needles Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Medication Preparation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Drug Delivery
  • 7.4. Blood Collection and Processing
  • 7.5. Others

8. Filter Needles Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Diagnostic Laboratories
  • 8.6. Academic Research Institutes
  • 8.7. Others

9. Filter Needles Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Becton, Dickinson, and Company*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. B. Braun Medical Inc.
  • 11.3. Cardinal Health
  • 11.4. MYCO Medical Supplies, Inc.
  • 11.5. Terumo Corporation
  • 11.6. ICU Medical, Inc.
  • 11.7. GBUK Group Ltd.
  • 11.8. Changzhou SUNTON Medical Technology Co., Ltd
  • 11.9. Medline Industries, LP

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us